Related Experiment Video
Updated: Jul 18, 2026
23:56
Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
High unmet-need infectious disease opportunities
1Cubist Pharmaceuticals Inc, 65 Hayden Avenue, Lexington, MA 02421, USA. praveen.tipirneni@cubist.com
Idrugs : the Investigational Drugs Journal
|November 11, 2006
Summary
Significant unmet needs persist in anti-infective therapies, particularly for Gram-negative infections, community-acquired methicillin-resistant Staphylococcus aureus, and Clostridium difficile. Increased pharmaceutical investment is crucial to address these growing microbial threats.
Area of Science:
- Pharmaceutical science
- Anti-infective therapies
- Microbial diseases
Background:
- Despite pharmaceutical science advances, substantial unmet needs remain in anti-infective treatments.
- Emerging microbial diseases are increasing in prevalence.
- Pharmaceutical research has concentrated on limited areas within anti-infectives.
Purpose of the Study:
- To identify key areas in anti-infective therapies representing significant commercial opportunities.
- To highlight the need for dedicated investment in combating emerging microbial infections.
Main Methods:
- Analysis of current trends in pharmaceutical research and development for anti-infectives.
- Identification of prevalent and emerging microbial threats.
- Assessment of commercial potential in specific anti-infective market segments.
Main Results:
- Three critical areas present major commercial opportunities: Gram-negative infections, community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA), and Clostridium difficile-associated diarrhea (CDAD).
- These conditions represent growing threats requiring urgent therapeutic solutions.
Conclusions:
- Substantial pharmaceutical company dedication and investment are essential to combat these emerging and life-threatening microbial infections.
- Addressing these specific anti-infective needs is vital for public health and commercial success.
Related Concept Videos
01:28Infectious Diseases and Their Occurrence
Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable temporal or...
01:25Immunodeficiency Diseases
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
There are three main causes of immunodeficiency disorders...
01:23Investigation of Disease Outbreaks
Multistate foodborne outbreaks pose significant public health risks and require meticulous investigation to identify sources and implement control measures. The Centers for Disease Control and Prevention (CDC) utilizes a dynamic seven-step process for these investigations, integrating data from laboratories, interviews, and environmental assessments to protect public health.Outbreak Detection: The detection of multistate outbreaks typically begins with PulseNet, the CDC's national laboratory...
01:29Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:22Healthcare Associated Infections II: Preventive Measures
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
01:20Infection
When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...